Literature DB >> 3942544

Application of a self-tonometer to home tonometry.

R C Zeimer, J T Wilensky, D K Gieser, D B Welch, M T Mori, D Kahanic.   

Abstract

Although home tonometry has been advocated in the management and diagnosis of glaucoma, the lack of proper instrumentation has precluded its routine performance. We have developed a self-tonometer that can be used by the patient at home and at work and have evaluated the performance of the instrument under these conditions. The results show that reproducibility of self-tonometer measurements is +/- 1.4 mm Hg and is independent of the user. When the readings of the self-tonometer in a given individual were compared with those of the Goldmann tonometer, they varied by +/- 2.4 mm Hg. Patients who could be trained in the clinic performed well and safely on their own. An average of fewer than five attempts was necessary to obtain four readings at each time of day. Our preliminary findings obtained during home tonometry demonstrated some of the benefits of repeated diurnal curves.

Entities:  

Mesh:

Year:  1986        PMID: 3942544     DOI: 10.1001/archopht.1986.01050130059020

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

1.  The Pulsair-Keeler non-contact tonometer in self-tonometry: preliminary results.

Authors:  B Boles Carenini; B Brogliatti; C Tonetto; E Renis
Journal:  Int Ophthalmol       Date:  1992-09       Impact factor: 2.031

2.  Familial iris melanosis--a misnomer?

Authors:  B C Joondeph; M F Goldberg
Journal:  Br J Ophthalmol       Date:  1989-04       Impact factor: 4.638

3.  The relation between intraocular pressure peak in the water drinking test and visual field progression in glaucoma.

Authors:  R Susanna; R M Vessani; L Sakata; L C Zacarias; M Hatanaka
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

4.  Diurnal intraocular pressure variations: an analysis of 690 diurnal curves.

Authors:  R David; L Zangwill; D Briscoe; M Dagan; R Yagev; Y Yassur
Journal:  Br J Ophthalmol       Date:  1992-05       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.